LACTOSE (INDIA)
Back to Cashflow Statement
|
LACTOSE (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹19 Cr | ₹-5.72 Cr | ₹-8.32 Cr | ₹-8.14 Cr | ₹4.52 Cr |
What is the latest Cash Flow from Financing Activities ratio of LACTOSE (INDIA) ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹-5.72 Cr |
| Mar2023 | ₹-8.32 Cr |
| Mar2022 | ₹-8.14 Cr |
| Mar2021 | ₹4.52 Cr |
How is Cash Flow from Financing Activities of LACTOSE (INDIA) Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | Positive | |
| Mar2024 | ₹-5.72 Cr | Negative | |
| Mar2023 | ₹-8.32 Cr | Negative | |
| Mar2022 | ₹-8.14 Cr | Negative | |
| Mar2021 | ₹4.52 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹133.7 Cr | 6.1% | 1% | 8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | 6.1% |
1% |
8.7% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses